Poly Medicure Share Price

  • 2,060.408.41 (0.41%)
  • Volume: 4,95,137
  • Closed
  • Last Updated On: 20 Jun, 2025, 03:52 PM IST
Loading...
Poly Medicure Share Price
  • 2,060.408.41 (0.41%)
  • Volume: 4,95,137
Advertisment
Stock Recommendations
  • Potential
    Upside

  • 1 Year
    Target

SELL

Mean Recos by
4 Analysts

1

2

0

1

0

Strong Sell

Sell

Hold

Buy

Strong Buy

Unlock Potential Upside
Stock Reports Plus

/10

Stock Score

View Report
Earnings
Fundamentals
Relative Valuation
Risk
Price Momentum
No Rating (NR)
Negative
Neutral
Positive
Unlock Stock Score

Poly Medicure share price insights

View All
  • In the last 13 years, only 2.54 % trading sessions saw intraday declines higher than 5 % .

  • Company has spent less than 1% of its operating revenues towards interest expenses and 18.06% towards employee cost in the year ending Mar 31, 2025. (Source: Consolidated Financials)

  • Black Marubozu(s) was formed for Poly Medicure

  • Poly Medicure is a part of Mid-cap Growth Stocks Screener

  • Poly Medicure Ltd. share price moved up by 0.41% from its previous close of Rs 2,052.00. Poly Medicure Ltd. stock last traded price is 2,060.40

    Share PriceValue
    Today/Current/Last2,060.40
    Previous Day2,052.002,053.50

InsightsPoly Medicure

    Do you find these insights useful?

    • hate it

    • meh

    • love it

    Key Metrics

    PE Ratio
    (x)
    61.67
    EPS - TTM
    (₹)
    33.41
    MCap
    (₹ Cr.)
    20,873.10
    Sectoral MCap Rank
    9
    PB Ratio
    (x)
    7.52
    Div Yield
    (%)
    0.17
    Face Value
    (₹)
    5.00
    Beta

    Beta

    1 Month-0.14
    3 Months0.14
    6 Months0.18
    1 Year0.41
    3 Years0.53

    -0.14
    VWAP
    (₹)
    2,071.06
    52W H/L
    (₹)
    3,357.80 / 1,810.15

    Poly Medicure Share Price Returns

    1 Day0.41%
    1 Week-7.23%
    1 Month-15.91%
    3 Months-8.11%
    1 Year2.96%
    3 Years208.56%
    5 Years593.04%

    ET Stock ScreenersTop Score Companies

    Check whether Poly Medicure belongs to analysts' top-rated companies list?

    View Stock Screeners

    Poly Medicure Share Recommendations

    Recent Recos

    SELL

    Current

    Mean Recos by 4 Analysts

    Strong
    Sell
    SellHoldBuyStrong
    Buy
    • Target₹1035
    • OrganizationHDFC Securities
    • BUY
    • Target₹925
    • OrganizationICICI Securities
    • BUY

    Analyst Trends

    RatingsCurrent1 Week Ago1 Month Ago3 Months Ago
    Strong Buy--11
    Buy1111
    Hold---1
    Sell2221
    Strong Sell111-
    # Analysts4454

    Poly Medicure Financials

    • Insights

      • Employee & Interest Expense

        Company has spent less than 1% of its operating revenues towards interest expenses and 18.06% towards employee cost in the year ending Mar 31, 2025. (Source: Consolidated Financials)
      Quarterly | AnnualMar 2025Dec 2024Sep 2024Jun 2024Mar 2024
      Total Income465.14446.01446.11401.70393.05
      Total Income Growth (%)4.29-0.0211.062.2010.36
      Total Expenses342.40331.18324.79300.08297.47
      Total Expenses Growth (%)3.391.978.240.8812.30
      EBIT122.74114.83121.32101.6295.58
      EBIT Growth (%)6.89-5.3519.396.324.70
      Profit after Tax (PAT)91.8385.2387.4574.0468.36
      PAT Growth (%)7.75-2.5518.128.315.14
      EBIT Margin (%)26.3925.7527.2025.3024.32
      Net Profit Margin (%)19.7419.1119.6018.4317.39
      Basic EPS (₹)8.928.489.017.717.12
      Quarterly | AnnualMar 2025Dec 2024Sep 2024Jun 2024Mar 2024
      Total Income444.92432.68429.71384.26376.59
      Total Income Growth (%)2.830.6911.832.0411.61
      Total Expenses326.26316.17309.65285.20279.68
      Total Expenses Growth (%)3.192.108.571.9710.99
      EBIT118.66116.52120.0699.0696.91
      EBIT Growth (%)1.84-2.9521.212.2213.42
      Profit after Tax (PAT)86.6685.1587.2272.3070.53
      PAT Growth (%)1.77-2.3720.632.5114.76
      EBIT Margin (%)26.6726.9327.9425.7825.73
      Net Profit Margin (%)19.4819.6820.3018.8218.73
      Basic EPS (₹)8.408.488.997.537.35
      Quarterly | Annual FY 2025 FY 2024 FY 2023 FY 2022 FY 2021
      Total Revenue1,758.961,434.541,151.42960.97804.88
      Total Revenue Growth (%)22.6124.5919.8219.3914.05
      Total Expenses1,311.621,092.80915.85768.17628.14
      Total Expenses Growth (%)20.0219.3219.2322.297.91
      Profit after Tax (PAT)338.56258.26179.28146.51135.87
      PAT Growth (%)31.0944.0522.377.8241.72
      Operating Profit Margin (%)27.5025.6621.9121.3423.55
      Net Profit Margin (%)20.2718.7716.0715.8717.27
      Basic EPS (₹)34.1326.9218.6915.2815.25
      Quarterly | Annual FY 2025 FY 2024 FY 2023 FY 2022 FY 2021
      Total Revenue1,691.571,365.431,104.33918.09766.67
      Total Revenue Growth (%)23.8923.6420.2919.7515.33
      Total Expenses1,248.681,030.53867.51723.37593.29
      Total Expenses Growth (%)21.1718.7919.9321.939.27
      Profit after Tax (PAT)331.33251.72179.04146.02129.51
      PAT Growth (%)31.6340.5922.6212.7440.19
      Operating Profit Margin (%)28.3626.4322.9522.5524.25
      Net Profit Margin (%)20.6819.2516.7616.6017.32
      Basic EPS (₹)33.4026.2418.6715.2314.54

      All figures in Rs Cr, unless mentioned otherwise

    • Annual FY 2025 FY 2024 FY 2023 FY 2022 FY 2021
      Total Assets3,192.451,858.671,577.211,376.831,223.73
      Total Assets Growth (%)71.7617.8514.5512.5159.48
      Total Liabilities426.79388.62335.58289.35258.16
      Total Liabilities Growth (%)9.8215.8015.9812.08-22.36
      Total Equity2,765.661,470.051,241.631,087.48965.57
      Total Equity Growth (%)88.1318.4014.1712.63122.06
      Current Ratio (x)5.182.402.753.464.12
      Total Debt to Equity (x)0.060.120.120.120.11
      Contingent Liabilities0.00229.96163.99169.5899.20
      Annual FY 2025 FY 2024 FY 2023 FY 2022 FY 2021
      Total Assets3,140.361,821.351,537.761,333.961,187.41
      Total Assets Growth (%)72.4218.4415.2812.3460.47
      Total Liabilities396.14363.10303.64256.99233.40
      Total Liabilities Growth (%)9.1019.5818.1510.11-24.87
      Total Equity2,744.221,458.251,234.121,076.97954.01
      Total Equity Growth (%)88.1918.1614.5912.89122.23
      Current Ratio (x)5.442.422.813.654.44
      Total Debt to Equity (x)0.060.110.110.100.10
      Contingent Liabilities0.00229.96163.99169.5899.20

      All figures in Rs Cr, unless mentioned otherwise

    • Insights

      • Cash from Operations vs PAT

        Operating cash flow of Rs 240.42 cr is 0.71 times compared to the reported net profit of Rs 338.56 cr. (Source: Consolidated Financials)
      • Increase in Cash from Investing

        Company has used Rs 1194.28 cr for investing activities which is an YoY increase of 395.68%. (Source: Consolidated Financials)
      Annual FY 2025 FY 2024 FY 2023 FY 2022 FY 2021
      Net Cash flow from Operating Activities240.42266.08190.83123.47118.73
      Net Cash used in Investing Activities-1,194.28-240.94-179.02-85.33-435.58
      Net Cash flow from Financing Activities950.51-20.15-12.51-35.34316.95
      Net Cash Flow-3.354.99-0.702.800.10
      Closing Cash & Cash Equivalent8.7012.057.067.764.95
      Closing Cash & Cash Equivalent Growth (%)-27.8370.67-8.9656.572.00
      Total Debt/ CFO (x)0.740.640.771.010.86
      Annual FY 2025 FY 2024 FY 2023 FY 2022 FY 2021
      Net Cash flow from Operating Activities236.65256.10194.86126.26116.40
      Net Cash used in Investing Activities-1,191.17-237.02-187.22-88.71-434.41
      Net Cash flow from Financing Activities952.93-17.32-7.89-39.71318.92
      Net Cash Flow-1.591.76-0.25-2.160.90
      Closing Cash & Cash Equivalent0.552.140.380.632.79
      Closing Cash & Cash Equivalent Growth (%)-74.41459.99-39.57-77.3447.51
      Total Debt/ CFO (x)0.720.630.690.870.78

      All figures in Rs Cr, unless mentioned otherwise

    • Annual FY 2025 FY 2024 FY 2023 FY 2022 FY 2021
      Return on Equity (%)12.2417.5614.4313.4714.07
      Return on Capital Employed (%)16.2723.4219.0317.1317.60
      Return on Assets (%)10.6013.8911.3610.6411.10
      Interest Coverage Ratio (x)45.1836.9034.1258.9921.76
      Asset Turnover Ratio (x)0.660.800.730.6964.26
      Price to Earnings (x)67.1159.1751.0262.1157.80
      Price to Book (x)8.2110.377.368.378.12
      EV/EBITDA (x)41.9736.6230.2036.6933.99
      EBITDA Margin (%)32.4530.3027.0427.1929.59
      Annual FY 2025 FY 2024 FY 2023 FY 2022 FY 2021
      Return on Equity (%)12.0717.2614.5013.5513.57
      Return on Capital Employed (%)16.2323.1319.3117.5317.50
      Return on Assets (%)10.5513.8211.6410.9410.90
      Interest Coverage Ratio (x)46.9137.9636.2369.5522.91
      Asset Turnover Ratio (x)0.650.780.740.7062.94
      Price to Earnings (x)68.9760.6151.2862.5060.61
      Price to Book (x)8.2810.467.418.458.22
      EV/EBITDA (x)42.5037.4630.2636.6734.72
      EBITDA Margin (%)33.4031.1828.1628.5230.45

    Financial InsightsPoly Medicure

    • Income (P&L)
    • Cash Flow
      • Employee & Interest Expense

        Company has spent less than 1% of its operating revenues towards interest expenses and 18.06% towards employee cost in the year ending Mar 31, 2025. (Source: Consolidated Financials)

      • Cash from Operations vs PAT

        Operating cash flow of Rs 240.42 cr is 0.71 times compared to the reported net profit of Rs 338.56 cr. (Source: Consolidated Financials)

      • Increase in Cash from Investing

        Company has used Rs 1194.28 cr for investing activities which is an YoY increase of 395.68%. (Source: Consolidated Financials)

    Do you find these insights useful?

    • hate it

    • meh

    • love it

    Poly Medicure Share Price Forecast

    • Get multiple analysts’ prediction on Poly Medicure

      Stock Forecast Non Prime User
      • High, low, medium predictions for Price
      • Upcoming predictions for Revenue
      • Details about company earnings
      START FREE TRIAL
    • Get multiple analysts’ prediction on Poly Medicure

      Stock Forecast Non Prime User
      • High, low, medium predictions for Price
      • Upcoming predictions for Revenue
      • Details about company earnings
      START FREE TRIAL
    • Get multiple analysts’ prediction on Poly Medicure

      Stock Forecast Non Prime User
      • High, low, medium predictions for Price
      • Upcoming predictions for Revenue
      • Details about company earnings
      START FREE TRIAL

    Poly Medicure Technicals

    • Stock doesn't have any Buy/Sell Signals.

    • 44%
      Positive Movement since
      1st Jan 2005 on basis
      55%
      Negative Movement since
      1st Jan 2005 on basis
      Exclude
    • Pivot Levels

      R1R2R3PIVOTS1S2S3
      Classic2101.172141.932213.732070.132029.371998.331926.53

      Average True Range

      5 DAYS14 DAYS28 DAYS
      ATR64.7171.2284.38

    Poly Medicure Peer Comparison

      • 1D
      • 1W
      • 1M
      • 3M
      • 6M
      • 1Y
      • 5Y
      Loading...
    • Ratio Performance

      NAMEP/E (x)P/B (x)ROE %ROCE %ROA %Rev CAGR [3Yr]OPMNPMBasic EPSCurrent RatioTotal Debt/ Equity (x)Total Debt/ CFO (x)
      Poly Medicure62.377.6312.2416.2710.6022.0827.5019.9634.135.180.060.74
      Nureca Ltd314.541.370.431.290.40-22.392.330.770.8515.320.01-0.12
      Add More
      Annual Ratios (%)

      Choose from Peers

        Choose from Stocks

        Peers InsightsPoly Medicure

          Do you find these insights useful?

          • hate it

          • meh

          • love it

          Poly Medicure Shareholding Pattern

          • Loading...
            Showing Poly Medicure Shareholding as on Mar 2025
            CategoryMar 2025Dec 2024Sep 2024Jun 2024
            Promoters62.4462.4462.5666.03
            Pledge0.000.000.000.00
            FII11.4512.3311.889.91
            DII11.9611.6612.339.34
            Mutual Funds7.167.177.356.29
            Others14.1513.5713.2314.71
          • Showing Shareholding as on Mar 2025
            CategoryNo. of SharesPercentage% Change QoQ
            Promoters6,32,65,34062.44 %0.00
            Pledge00.00 %0.00
            FII1,16,08,65611.45 %-0.87
            DII1,21,18,40811.96 %0.30
            MF72,55,9597.16 %0.00
            Others1,43,33,31114.15 %0.57

          Poly Medicure MF Ownership

          MF Ownership as on 31 May 2025

          Poly Medicure Corporate Actions

          • Meeting DateAnnounced onPurposeDetails
            May 06, 2025Apr 29, 2025Board MeetingAudited Results & Final Dividend
            Feb 03, 2025Jan 27, 2025Board MeetingQuarterly Results & Others
            Jan 25, 2025Dec 24, 2024POM-
            Oct 28, 2024Oct 21, 2024Board MeetingQuarterly Results & ESOP
            Sep 26, 2024Sep 10, 2024AGMRs.3.0000 per share(60%)Final Dividend & A.G.M.
          • TypeDividendDividend per ShareEx-Dividend DateAnnounced on
            Final60%3.0Sep 19, 2024May 17, 2024
            Final60%3.0Sep 21, 2023May 09, 2023
            Final50%2.5Sep 16, 2022May 24, 2022
            Final50%2.5Sep 16, 2021May 24, 2021
            Final70%3.5-May 06, 2025
          • All TypesEx-DateRecord DateAnnounced onDetails
            BonusMar 24, 2017Mar 28, 2017Feb 06, 2017Bonus Ratio: 1 share(s) for every 1 shares held
            SplitsFeb 02, 2015Feb 03, 2015Nov 05, 2014Split: Old FV10.0| New FV:5.0
            BonusJul 09, 2013Jul 10, 2013May 13, 2013Bonus Ratio: 1 share(s) for every 1 shares held
            BonusMar 26, 2010Mar 29, 2010Feb 09, 2010Bonus Ratio: 1 share(s) for every 1 shares held

          About Poly Medicure

          Poly Medicure Ltd., incorporated in the year 1995, is a Small Cap company (having a market cap of Rs 20,792.04 Crore) operating in Hospitals & Allied Services sector. Poly Medicure Ltd. key Products/Revenue Segments include Medical Equipments & Accessories, Export Incentives, Scrap for the year ending 31-Mar-2024. Show More

          • Executives

          • Auditors

          • DR

            Devendra Raj Mehta

            Chairman
            HB

            Himanshu Baid

            Managing Director
            RB

            Rishi Baid

            Joint Managing Director
            AB

            Alessandro Balboni

            Non Executive Director
            Show More
          • M C Bhandari & Co.

          FAQs about Poly Medicure share

          • 1. What's the Poly Medicure share price today?
            Poly Medicure share price is Rs 2,060.40 as on 20 Jun, 2025, 03:55 PM IST. Poly Medicure share price is up by 0.41% based on previous share price of Rs. 2135.6. In last 1 Month, Poly Medicure share price moved down by 15.91%.
          • 2. What's the market capitalization of Poly Medicure?
            Within the Hospitals & Allied Services sector, Poly Medicure stock has a market cap rank of 9. Poly Medicure has a market cap of Rs 20,873.10 Cr.
          • 3. What is Poly Medicure's 52 week high / low?
            52 Week high of Poly Medicure share is Rs 3,357.80 while 52 week low is Rs 1,810.15
          • 4. What are the returns for Poly Medicure share?
            Return Performance of Poly Medicure Shares:
            • 1 Week: Poly Medicure share price moved down by 7.23%
            • 1 Month: Poly Medicure share price moved down by 15.91%
            • 3 Month: Poly Medicure share price moved down by 8.11%
            • 6 Month: Poly Medicure share price moved down by 20.62%
          • 5. What is the PE & PB ratio of Poly Medicure?
            The PE ratio of Poly Medicure stands at 61.41, while the PB ratio is 7.52.

          Trending in Markets

          Top Gainers As on 03:57 PM | 20 Jun 2025

          Waaree Energies2,989.00
          317.81 (11.90%)
          BEML4,639.50
          351.70 (8.21%)
          RattanIndia Infra59.12
          4.01 (7.28%)
          Endurance Tech.2,576.00
          161.00 (6.67%)
          Premier Energies1,028.40
          60.41 (6.24%)

          Top Losers As on 03:58 PM | 20 Jun 2025

          Concord Biotech Ltd.1,837.30
          -136.00 (-6.90%)
          Eris Lifesciences1,626.60
          -109.21 (-6.30%)
          AstraZeneca8,871.00
          -539.50 (-5.74%)
          Intellect Design1,077.80
          -64.11 (-5.62%)
          Gillette India9,900.00
          -490.00 (-4.72%)

          DATA SOURCES: TickerPlant (for live BSE/NSE quotes service) and Dion Global Solutions Ltd. (for corporate data, historical price & volume, F&O data). Sensex & BSE Quotes and Nifty & NSE Quotes are real-time and licensed from BSE and NSE respectively. All timestamps are reflected in IST (Indian Standard Time).

          DISCLAIMER: Any and all content on this website including tools/analysis is provided to you only for convenience and on an “as-is, as- available” basis without representation and warranties of any kind. The content and any output of such tools/analysis is for informational purposes only and should not be relied upon or construed as an investment advice or guarantee for any specific performance/returns advice or considered as recommendation for the purchase or sale of any security or investment. You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions.

          By using this site, you agree to the Terms of Service and Privacy Policy.

          The Economic Times